Dr. Anton HagenbeekProfessor of Hematology
Academic Medical Center, University of Amsterdam,
Anton received his MD from the Erasmus University in Rotterdam. He was trained in experimental hematology at the Radiobiological Institute T.N.O. in Rijswijk where he obtained his PhD followed by training in internal medicine/hematology in Rotterdam, and as a fellow in hematology at UCLA.
He worked as a staff member of the Dr Daniel den Hoed Cancer Center in Rotterdam, Department of Hematology for 15 years, and was in charge of the autologous and allogeneic stem cell transplantation program there between 1987 and 1994. In 1993 he was appointed Professor of Clinical and Experimental Hemato-Oncology, at the Erasmus University, Rotterdam, where his main research interests were in developmental therapeutics for leukemia, focussing on translational research from preclinical animal models and in vitro studies to clinical application. From studies on minimal residual disease and experimental bone marrow transplantation (GVHD-GVL) in the early 1980s, he moved into immuno-gene therapy of hematological malignancies. To date, his clinical research activities are mainly in the field of (intergroup) studies in non-Hodgkin’s lymphomas and Hodgkin lymphomas. He has established two (international) consortia dealing with developing new biological prognostic indices in lymphoma and running first-in-man Phase I/II studies with new agents in the lymphomas and chronic lymphocytic leukaemia (CLL).
He has co-authored 345 papers in peer-reviewed journals. In 1997, he was appointed Professor of Hematology at the University Medical Center Utrecht, The Netherlands. He is currently Professor of Hematology in the Department of Hematology, Academic Medical Center, University of Amsterdam, the Netherlands.